Therefore, IC administration in the in vitro APS model specifically strengthened the H3K4me3 signal and chromatin accessibility at the FOXJ2 promoter, which facilitated FOXJ2 expression in APS. The gene discussed is FOXJ2; the disease is autoimmune polyendocrinopathy.